Cite
MLA Citation
Joel Kremer et al.. “OP0028 POST-APPROVAL COMPARATIVE SAFETY STUDY OF TOFACITINIB AND BIOLOGIC DMARDS: FIVE–YEAR RESULTS FROM A US-BASED RHEUMATOID ARTHRITIS REGISTRY.” Annals of the rheumatic diseases, vol. 78, n.d., pp. 82–83. http://access.bl.uk/ark:/81055/vdc_100144723131.0x000054